11.02.2022 • News

Azelis Takes Turkey’s Tunckaya

Azelis has signed a deal to acquire Tunckaya, a Turkish food ingredients and additives distributor, further strengthening its position in the country’s fast-growing market for food, as well as the broader life sciences sector. The Istanbul-based company employs 25 people and serves more than 500 customers.

The transaction is expected to close in the first quarter of 2022, subject to customary closing conditions.

Tunckaya, with its strong relationships in the food market and general market position “is a fantastic addition for our lateral value chain and complements the organic growth of Azelis,” said Sertaç Sürür, managing director of Azelis Turkey. “We look forward to combining our talents and leveraging our combined capabilities and expertise for our customers and principals in Turkey and across the wider EMEA region.”

Last November, Azelis opened a new laboratory in Istanbul for coatings, adhesives, sealants and elastomers (CASE). The Belgium-based  distributor said this enables it to accelerate the roll-out of innovative CASE formulations and technical support to customers in the region.

The laboratory is mostly focused on coatings, including paints and varnishes, in industrial, decorative, marine, can and coil, wood and other markets. It is the first CASE laboratory in Azelis’s Application and Training Center in Turkey, which already runs separate laboratories for food, pharma, home care & industrial cleaning and personal care.

Author: Elaine Burridge, Freelance Journalist

(c) Azelis
(c) Azelis

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.